IM

Ian Moore

Proteomics International Laboratories Ltd | Non-Executive Director
Mr Moore has 40 years experience in the international pharmaceutical industry, including almost 30 years as President of Novo Nordisk Japan (Novo Nordisk is the world's largest manufacturer of diabetes therapeutics including Insulin and a global leader in diabetes care). Roger established Novo's organisation in Japan as the first employee in 1977, and worked for the company until his retirement as Chairman at the end of 2007. In 2000 Roger was appointed Senior Vice President, responsible for Novo Nordisk's business in Japan, Australia, New Zealand and the Pacific , and also a member of the Senior Management Board of Novo Nordisk A/S. In 2007, Roger was awarded the Knight's Cross of the Order of the Dannebrog(R) by Queen Margrethe II of Denmark.

Company and Role

Company
Title
Tenure
Since
PIQ
Proteomics International Laboratories Ltd
  • Non-Executive Director
7yrs, 9mthOct 2016

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PIQ
Proteomics International Laboratories Ltd
30/06/23975,824N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PIQ
Proteomics International Laboratories Ltd
24/11/22
Issued
58,824$0.850$50,000Placement
PIQ
Proteomics International Laboratories Ltd
24/10/22
Exercise
100,000$0.670$67,000Exercise of options
PIQ
Proteomics International Laboratories Ltd
24/10/22
Issued
100,000$0.670$67,000Exercise of options
PIQ
Proteomics International Laboratories Ltd
04/11/21
Issued
100,000$0.500$50,000Exercise of options
PIQ
Proteomics International Laboratories Ltd
04/11/21
Exercise
100,000$0.500$50,000Exercise of options